MARY FISHER PINSON: Open Payments
NPI 1598790230 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 17 payments from 7 companies in 2025. Trend: 2023 $1,245 · 2024 $906 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $250 |
| Teva Pharmaceuticals USA, Inc. | 3 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $105 |
| Corium, LLC | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Alkermes, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $16 |
Products named: INGREZZA, AUSTEDO XR, CAPLYTA, REXULTI, Azstarys, LYBALVI.
Industry payments across AZ — which companies pay providers there.
